Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines

Laxmaiah Manchikanti, Adam M. Kaye, Nebojsa Nick Knezevic, Heath McAnally, Andrea M. Trescot, Susan Blank, Vidyasagar Pampati, Salahadin Abdi, Jay S. Grider, Alan D. Kaye, Kavita N. Manchikanti, Harold J. Cordner, Christopher G. Gharibo, Michael E. Harned, Sheri L. Albers, Sairam Atluri, Steve M. Aydin, Sanjay Bakshi, Robert Barkin, Ramsin M. BenyaminMark V. Boswell, Ricardo M. Buenaventura, Aaron K. Calodney, David L. Cedeno, Sukdeb Datta, Timothy R. Deer, Bert Fellows, Vincent Galan, Vahid Grami, Hans Hansen, Standiford Helm, Rafael Justiz, Dhanalakshmi Koyyalagunta, Yogesh Malla, Annu Navani, Kent Nouri, Ramarao Pasupuleti, Nalini Sehgal, Sanford M. Silverman, Thomas T. Simopoulos, Vijay Singh, Konstantin V. Slavin, Daneshvari R. Solanki, Peter S. Staats, Ricardo Vallejo, Bradley W. Wargo, Arthur Watanabe, Joshua A. Hirsch

Research output: Contribution to journalArticlepeer-review

346 Scopus citations


Background: Opioid use, abuse, and adverse consequences, including death, have escalated at an alarming rate since the 1990s. In an attempt to control opioid abuse, numerous regulations and guidelines for responsible opioid prescribing have been developed by various organizations. However, the US opioid epidemic is continuing and drug dose deaths tripled during 1999 to 2015. Recent data show a continuing increase in deaths due to natural and semisynthetic opioids, a decline in methadone deaths, and an explosive increase in the rates of deaths involving other opioids, specifically heroin and illicit synthetic fentanyl. Contrary to scientific evidence of efficacy and negative recommendations, a significant proportion of physicians and patients (92%) believe that opioids reduce pain and a smaller proportion (57%) report better quality of life. In preparation of the current guidelines, we have focused on the means to reduce the abuse and diversion of opioids without jeopardizing access for those patients suffering from non-cancer pain who have an appropriate medical indication for opioid use. Objectives: To provide guidance for the prescription of opioids for the management of chronic non-cancer pain, to develop a consistent philosophy among the many diverse groups with an interest in opioid use as to how appropriately prescribe opioids, to improve the treatment of chronic non-cancer pain and to reduce the likelihood of drug abuse and diversion. These guidelines are intended to provide a systematic and standardized approach to this complex and difficult arena of practice, while recognizing that every clinical situation is unique. Methods: The methodology utilized included the development of objectives and key questions. The methodology also utilized trustworthy standards, appropriate disclosures of conflicts of interest, as well as a panel of experts from various specialties and groups. The literature pertaining to opioid use, abuse, effectiveness, and adverse consequences was reviewed, with a best evidence synthesis of the available literature, and utilized grading for recommendation as described by the Agency for Healthcare Research and Quality (AHRQ).

Original languageEnglish (US)
Pages (from-to)S3-S92
JournalPain physician
Issue number2
StatePublished - Feb 2017

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine


Dive into the research topics of 'Responsible, safe, and effective prescription of opioids for chronic non-cancer pain: American society of interventional pain physicians (ASIPP) guidelines'. Together they form a unique fingerprint.

Cite this